Plain-English translation of NCT05473156 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing a new medication called in people with advanced cancers that have spread or cannot be surgically removed. Researchers want to learn whether the medication is safe, how the body processes it, and whether it can help shrink tumors. The trial is recruiting patients with several types of cancer, including lung cancer, head and neck cancer, and esophageal cancer.
Standard cancer treatments don't work for everyone, and some patients develop resistance to existing therapies. This medication is being studied to see if it offers a new treatment option for patients whose cancers have stopped responding to conventional care.
You likely qualify if…
You likely don't qualify if…
You would receive doses of the medication as part of a carefully controlled study where doses are gradually increased to find the safest level. You would visit the study site regularly for check-ups, blood tests, imaging scans, and other tests to monitor how the medication affects your cancer and your overall health. The trial is still recruiting, and your doctors would discuss the exact schedule and what to expect during your participation.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Taiwan